The study objective is to observe and measure clinical outcomes, urine output, and safety events occurring during standard medical treatment of ADHF patients deemed to have insufficient diuretic response.
Study Type
OBSERVATIONAL
Enrollment
6
Standard medical treatment of ADHF patients deemed to have insufficient diuretic response.
Weill Cornell
New York, New York, United States
Columbia University Irving Medical Center
New York, New York, United States
Montefiore Medical Center - Moses Campus
New York, New York, United States
St Francis Hospital
New York, New York, United States
Serious Adverse Events
SAEs (including MACE) post enrollment based on CEC adjudication.
Time frame: 30 days
Serum Creatinine
Change in level
Time frame: Baseline [T=0] and 48 hours
Urine Output
Change in the rate
Time frame: Baseline [T=0-12h] and through 24 hours [T=12-36h]
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.